Evidence map›Paper›PMID 32552462›Full record

ArticleJournal of biomolecular structure & dynamics2021

Identification of bioactive compounds from

Saurabh K Sinha, Satyendra K Prasad, Md Ataul Islam, Shailendra S Gurav, Rajesh B Patil, Nora Abdullah AlFaris, Tahany Saleh Aldayel, Nora M AlKehayez, Saikh Mohammad Wabaidur, Anshul Shakya

Open access · greenAbstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Stemness reducible effects of glyasperin A against NCCIT teratocarcinomas.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Advancements in the development of antivirals against SARS-Coronavirus.Frontiers in cellular and infection microbiology · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Steroidal lactones fromIn silico pharmacology · 2024
    Article
  14. Molecules (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Arabian journal of chemistry · 2023
    Article
  17. Review
  18. Review
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 6 countries.

Saurabh K SinhaDepartment of Pharmaceutical Sciences, Mohanlal Shukhadia University, Udaipur, India.ORCID 0000-0002-1559-5989
Satyendra K PrasadDepartment of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India.ORCID 0000-0002-4762-9733
Md Ataul IslamDivision of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Shailendra S GuravGoa College of Pharmacy, Department of Pharmacognosy, Goa University, Panaji, India.ORCID 0000-0001-5564-2121
Rajesh B PatilSinhgad Technical Education Society's, Smt. Kashibai Navale College of Pharmacy, Pune, India.ORCID 0000-0003-2986-9546
Nora Abdullah AlFarisNutrition and Food Science, Department of Physical Sport Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID 0000-0002-9135-5725
Tahany Saleh AldayelNutrition and Food Science, Department of Physical Sport Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Nora M AlKehayezNutrition and Food Science, Department of Physical Sport Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Saikh Mohammad WabaidurDepartment of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Anshul ShakyaDepartment of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, India.ORCID 0000-0002-8232-4476
Princess Nourah bint Abdulrahman University · SADibrugarh University · INGoa University · INKing Saud University · SAManchester Academic Health Science Centre · GBMohanlal Sukhadia University · INRashtrasant Tukadoji Maharaj Nagpur University · INSmt. Kashibai Navale Medical College and General hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, the world is facing a pandemic named as COVID-19, caused by SARS-CoV-2. Traditional Chinese medicine has recommended the use of liquorice (Glycyrrhiza species) in the treatment of infections caused by SARS-CoV-2. Therefore, the present investigation was carried out to identify the active molecule from the liquorice against different protein targets of COVID-19 using an

Indexed as

GlycyrrhizaCOVID-19GlycoproteinsHumansMolecular Docking SimulationMolecular Dynamics SimulationSARS-CoV-2Spike Glycoprotein, CoronavirusGlycoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19glyasperinglycyrrhizic acidliquiritinliquorice

Identifiers

PMID32552462
PMCPMC7309308
OpenAlexW3036617393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.